Stefano Molica

5.5k total citations
170 papers, 3.0k citations indexed

About

Stefano Molica is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Stefano Molica has authored 170 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Genetics, 108 papers in Pathology and Forensic Medicine and 53 papers in Immunology. Recurrent topics in Stefano Molica's work include Chronic Lymphocytic Leukemia Research (143 papers), Lymphoma Diagnosis and Treatment (108 papers) and Immunodeficiency and Autoimmune Disorders (45 papers). Stefano Molica is often cited by papers focused on Chronic Lymphocytic Leukemia Research (143 papers), Lymphoma Diagnosis and Treatment (108 papers) and Immunodeficiency and Autoimmune Disorders (45 papers). Stefano Molica collaborates with scholars based in Italy, United Kingdom and United States. Stefano Molica's co-authors include Domenico Levato, Luciano Levato, Gaetano Vitelli, Diana Giannarelli, A Dattilo, Fortunato Morabito, Doménico Ribatti, Angelo Vacca, Pellegrino Musto and Vincenzo Liso and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stefano Molica

167 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Stefano Molica 1.9k 1.4k 980 765 726 170 3.0k
David Westerman 1.4k 0.8× 1.4k 1.0× 545 0.6× 576 0.8× 776 1.1× 125 2.8k
Marı́a Rozman 2.1k 1.1× 1.6k 1.1× 910 0.9× 1.0k 1.3× 631 0.9× 128 3.6k
Farrukh T. Awan 2.0k 1.1× 1.6k 1.1× 1.3k 1.3× 748 1.0× 976 1.3× 199 3.7k
Stephen Opat 1.4k 0.7× 1.7k 1.2× 562 0.6× 446 0.6× 980 1.3× 158 2.7k
Samantha Jaglowski 1.5k 0.8× 1.2k 0.9× 896 0.9× 466 0.6× 940 1.3× 152 2.9k
Nishitha Reddy 1.0k 0.5× 1.4k 1.0× 534 0.5× 378 0.5× 1.0k 1.4× 116 2.3k
Achille Ambrosetti 1.3k 0.7× 1.5k 1.1× 468 0.5× 383 0.5× 713 1.0× 67 2.8k
Andrzej Hellmann 1.8k 1.0× 1.3k 0.9× 711 0.7× 548 0.7× 589 0.8× 58 3.1k
M. Monconduit 1.9k 1.0× 2.1k 1.5× 824 0.8× 1.2k 1.6× 1.3k 1.8× 45 4.1k
Jeffrey Matous 1.6k 0.8× 2.3k 1.6× 831 0.8× 1.0k 1.3× 1.8k 2.5× 128 4.2k

Countries citing papers authored by Stefano Molica

Since Specialization
Citations

This map shows the geographic impact of Stefano Molica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Molica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Molica more than expected).

Fields of papers citing papers by Stefano Molica

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Molica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Molica. The network helps show where Stefano Molica may publish in the future.

Co-authorship network of co-authors of Stefano Molica

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Molica. A scholar is included among the top collaborators of Stefano Molica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Molica. Stefano Molica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliva, Stefano & Stefano Molica. (2025). Cardiovascular Challenges in Chronic Lymphocytic Leukemia ( CLL ) Patients Undergoing Bruton Tyrosine Kinase ( BTK ) Inhibitor Therapy. European Journal Of Haematology. 116(2). 104–115.
2.
Molica, Stefano. (2025). AMPLIFY: A second-generation BTK inhibitor for fixed-duration therapy in chronic lymphocytic leukemia. Med. 6(4). 100665–100665. 1 indexed citations
3.
Molica, Stefano. (2025). Navigating the gap between guidelines and practical challenges in selecting first-line therapy for chronic lymphocytic leukemia. Expert Review of Hematology. 18(3). 195–200. 1 indexed citations
4.
James, Daniel S., et al.. (2024). High‐Risk Chronic Lymphocytic Leukemia Complicating the Course of Imatinib‐Treated Chronic Myeloid Leukemia: Successful Disease Management With Dual Tyrosine Kinase Inhibition. SHILAP Revista de lepidopterología. 2024(1). 1813512–1813512. 1 indexed citations
5.
Molica, Stefano, Marco Rossi, & David Allsup. (2023). Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide. Acta Haematologica. 147(3). 257–259. 1 indexed citations
6.
Molica, Stefano, Constantine S. Tam, David Allsup, & Aaron Polliack. (2023). Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directions. Hematological Oncology. 42(1). 1 indexed citations
7.
Molica, Stefano, Constantine S. Tam, David Allsup, & Aaron Polliack. (2023). Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic Option. Cancers. 15(14). 3737–3737. 9 indexed citations
8.
Laurenti, Luca, Lydia Scarfò, Anna Maria Frustaci, et al.. (2023). Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience. Hematological Oncology. 41(4). 621–630. 4 indexed citations
9.
Molica, Stefano, Constantine S. Tam, & Aaron Polliack. (2022). Current perspectives regarding SARS‐CoV‐2 vaccination in chronic lymphocytic leukemia. Hematological Oncology. 40(3). 313–319. 3 indexed citations
10.
Molica, Stefano, Luca Laurenti, Paolo Ghia, et al.. (2021). COVID-19 Pandemic Impact on Chronic Lymphocytic Leukemia (CLL) Patients' Preferences Towards Therapies: The Italian Experience (CHOICE Study). Blood. 138(Supplement 1). 4690–4690. 1 indexed citations
11.
Molica, Stefano, John F. Seymour, & Aaron Polliack. (2021). A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agents. Hematological Oncology. 39(5). 595–604. 2 indexed citations
12.
Molica, Stefano, Estella Matutes, Constantine S. Tam, & Aaron Polliack. (2019). Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on. Hematological Oncology. 38(2). 129–136. 17 indexed citations
13.
Carillio, Guido & Stefano Molica. (2018). Unusual metastases of melanoma. Clinical Case Reports. 6(9). 1907–1908. 1 indexed citations
14.
Delgado, Julio, Michael Doubek, Tycho Baumann, et al.. (2017). Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers ( IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI. American Journal of Hematology. 92(4). 375–380. 66 indexed citations
15.
Molica, Stefano, Guido Carillio, & C Battaglia. (2016). Response to ibrutinib in chronic lymphocytic leukemia improves in quality with time. Clinical Case Reports. 5(1). 75–76. 1 indexed citations
16.
Fedele, Roberta, Giuseppe Messina, Tiziana Martinello, et al.. (2014). Tolerability and Efficacy of Busulfan and Fludarabine As Allogeneic Pretransplant Conditioning Therapy in Acute Myeloid Leukemia: Comparison With Busulfan and Cyclophosphamide Regimen. Clinical Lymphoma Myeloma & Leukemia. 14(6). 493–500. 6 indexed citations
17.
Martino, Massimo, Maurizio Postorino, Giuseppe Messina, et al.. (2013). Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs. Clinical Lymphoma Myeloma & Leukemia. 14(2). 148–154. 12 indexed citations
18.
Mosca, Laura, Sonia Fabris, Marta Lionetti, et al.. (2010). Integrative Genomics Analyses Reveal Molecularly Distinct Subgroups of B-Cell Chronic Lymphocytic Leukemia Patients with 13q14 Deletion. Clinical Cancer Research. 16(23). 5641–5653. 38 indexed citations
19.
Molica, Stefano, Giovanna Digiesi, Angelo Vacca, et al.. (2009). Does Adiponectin Act as an Antiangiogenic Factor in B-Cell Chronic Lymphocytic Leukemia?. Advances in Hematology. 2009. 1–6. 5 indexed citations
20.
Bonapace, Giuseppe, Francesco Iuliano, Stefano Molica, Antonio Peta, & Pietro Strisciuglio. (2004). Cytosolic carbonic anhydrase activity in chronic myeloid disorders with different clinical phenotype. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1689(3). 179–181. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Westerman Breakdown of academic impact, for papers by Marı́a Rozman Breakdown of academic impact, for papers by Farrukh T. Awan Breakdown of academic impact, for papers by Stephen Opat Breakdown of academic impact, for papers by Samantha Jaglowski Breakdown of academic impact, for papers by Nishitha Reddy Breakdown of academic impact, for papers by Achille Ambrosetti Breakdown of academic impact, for papers by Andrzej Hellmann Breakdown of academic impact, for papers by M. Monconduit Breakdown of academic impact, for papers by Jeffrey Matous
Rankless by CCL
2026